FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210943148> ?p ?o ?g. }

• W3210943148 endingPage "645" @default.
• W3210943148 startingPage "635" @default.
• W3210943148 abstract "Increasing prevalence of infections caused by antimicrobial-resistant gram-negative bacteria represents a global health crisis, and while several novel therapies that target various aspects of antimicrobial resistance have been introduced in recent years, few are currently approved for children. Ceftazidime-avibactam is a novel β-lactam β-lactamase inhibitor combination approved for adults and children 3 months and older with complicated intra-abdominal infection, and complicated urinary tract infection or hospital-acquired ventilator-associated pneumonia (adults only in the United States) caused by susceptible gram-negative bacteria. Extensive population pharmacokinetic (PK) data sets for ceftazidime and avibactam obtained during the adult clinical development program were used to iteratively select, modify, and validate the approved adult dosage regimen (2,000-500 mg by 2-hour intravenous (IV) infusion every 8 hours (q8h), with adjustments for renal function). Following the completion of one phase I (NCT01893346) and two phase II ceftazidime-avibactam studies (NCT02475733 and NCT02497781) in children, adult PK data sets were updated with pediatric PK data. This paper describes the development of updated combined adult and pediatric population PK models and their application in characterizing the population PK of ceftazidime and avibactam in children, and in dose selection for further pediatric evaluation. The updated models supported the approval of ceftazidime-avibactam pediatric dosage regimens (all by 2-hour IV infusion) of 50-12.5 mg/kg (maximum 2,000-500 mg) q8h for those ≥6 months to 18 years old, and 40-10 mg/kg q8h for those ≥3 to 6 months old with creatinine clearance > 50 mL/min/1.73 m2 ." @default.
• W3210943148 created "2021-11-08" @default.
• W3210943148 creator A5013657469 @default.
• W3210943148 creator A5019823948 @default.
• W3210943148 creator A5020646343 @default.
• W3210943148 creator A5023907922 @default.
• W3210943148 creator A5035996923 @default.
• W3210943148 creator A5044362651 @default.
• W3210943148 creator A5053015699 @default.
• W3210943148 creator A5059929229 @default.
• W3210943148 creator A5065766712 @default.
• W3210943148 creator A5081984076 @default.
• W3210943148 date "2021-11-22" @default.
• W3210943148 modified "2023-10-14" @default.
• W3210943148 title "Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older" @default.
• W3210943148 cites W1480294397 @default.
• W3210943148 cites W1550111394 @default.
• W3210943148 cites W1916323032 @default.
• W3210943148 cites W1969339065 @default.
• W3210943148 cites W2012987359 @default.
• W3210943148 cites W2018229558 @default.
• W3210943148 cites W2039431419 @default.
• W3210943148 cites W2044171598 @default.
• W3210943148 cites W2070839731 @default.
• W3210943148 cites W2088996598 @default.
• W3210943148 cites W2114559245 @default.
• W3210943148 cites W2122855609 @default.
• W3210943148 cites W2140518380 @default.
• W3210943148 cites W2152073293 @default.
• W3210943148 cites W2157019531 @default.
• W3210943148 cites W2252374742 @default.
• W3210943148 cites W2294833633 @default.
• W3210943148 cites W2339648279 @default.
• W3210943148 cites W2339819000 @default.
• W3210943148 cites W2437593726 @default.
• W3210943148 cites W2522293857 @default.
• W3210943148 cites W2589596684 @default.
• W3210943148 cites W2602847039 @default.
• W3210943148 cites W2773548512 @default.
• W3210943148 cites W2773797467 @default.
• W3210943148 cites W2775142203 @default.
• W3210943148 cites W2796052358 @default.
• W3210943148 cites W2884336796 @default.
• W3210943148 cites W2891577800 @default.
• W3210943148 cites W2900408982 @default.
• W3210943148 cites W2941659723 @default.
• W3210943148 cites W2961303957 @default.
• W3210943148 cites W2963565395 @default.
• W3210943148 cites W2995636661 @default.
• W3210943148 cites W2998394273 @default.
• W3210943148 cites W2998629375 @default.
• W3210943148 cites W3005408381 @default.
• W3210943148 cites W3034671949 @default.
• W3210943148 cites W3038933864 @default.
• W3210943148 cites W3092096709 @default.
• W3210943148 cites W3120705879 @default.
• W3210943148 cites W3128694216 @default.
• W3210943148 cites W4235275633 @default.
• W3210943148 doi "https://doi.org/10.1002/cpt.2460" @default.
• W3210943148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34687548" @default.
• W3210943148 hasPublicationYear "2021" @default.
• W3210943148 type Work @default.
• W3210943148 sameAs 3210943148 @default.
• W3210943148 citedByCount "7" @default.
• W3210943148 countsByYear W32109431482022 @default.
• W3210943148 countsByYear W32109431482023 @default.
• W3210943148 crossrefType "journal-article" @default.
• W3210943148 hasAuthorship W3210943148A5013657469 @default.
• W3210943148 hasAuthorship W3210943148A5019823948 @default.
• W3210943148 hasAuthorship W3210943148A5020646343 @default.
• W3210943148 hasAuthorship W3210943148A5023907922 @default.
• W3210943148 hasAuthorship W3210943148A5035996923 @default.
• W3210943148 hasAuthorship W3210943148A5044362651 @default.
• W3210943148 hasAuthorship W3210943148A5053015699 @default.
• W3210943148 hasAuthorship W3210943148A5059929229 @default.
• W3210943148 hasAuthorship W3210943148A5065766712 @default.
• W3210943148 hasAuthorship W3210943148A5081984076 @default.
• W3210943148 hasBestOaLocation W32109431481 @default.
• W3210943148 hasConcept C111113717 @default.
• W3210943148 hasConcept C112705442 @default.
• W3210943148 hasConcept C126322002 @default.
• W3210943148 hasConcept C177713679 @default.
• W3210943148 hasConcept C2775933652 @default.
• W3210943148 hasConcept C2776968632 @default.
• W3210943148 hasConcept C2777406300 @default.
• W3210943148 hasConcept C2777637488 @default.
• W3210943148 hasConcept C2908647359 @default.
• W3210943148 hasConcept C523546767 @default.
• W3210943148 hasConcept C54355233 @default.
• W3210943148 hasConcept C71924100 @default.
• W3210943148 hasConcept C86803240 @default.
• W3210943148 hasConcept C99454951 @default.
• W3210943148 hasConceptScore W3210943148C111113717 @default.
• W3210943148 hasConceptScore W3210943148C112705442 @default.
• W3210943148 hasConceptScore W3210943148C126322002 @default.
• W3210943148 hasConceptScore W3210943148C177713679 @default.
• W3210943148 hasConceptScore W3210943148C2775933652 @default.
• W3210943148 hasConceptScore W3210943148C2776968632 @default.

• next